4//SEC Filing
Brownie William 4
Accession 0001209191-23-046246
CIK 0001719395other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:12 PM ET
Size
24.1 KB
Accession
0001209191-23-046246
Insider Transaction Report
Form 4
Eargo, Inc.EAR
Brownie William
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-15+93,750→ 93,750 totalExercise: $3.31Exp: 2033-01-31→ Common Stock (93,750 underlying) - Sale
Common Stock
2023-08-17$3.23/sh−14$45→ 8,279 total - Award
Stock Option (Right to Buy)
2023-08-15+112,500→ 112,500 totalExercise: $3.31Exp: 2033-08-14→ Common Stock (112,500 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+93,750→ 93,750 totalExercise: $3.31Exp: 2033-01-31→ Common Stock (93,750 underlying) - Sale
Common Stock
2023-08-17$3.20/sh−1,500$4,806→ 6,779 total - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−93,750→ 0 totalExercise: $11.58Exp: 2033-01-31→ Common Stock (93,750 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−825→ 0 totalExercise: $1051.60Exp: 2031-01-28→ Common Stock (825 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-08-15−93,750→ 0 totalExercise: $11.58Exp: 2033-01-31→ Common Stock (93,750 underlying) - Award
Stock Option (Right to Buy)
2023-08-15+825→ 825 totalExercise: $3.31Exp: 2031-01-28→ Common Stock (825 underlying)
Footnotes (8)
- [F1]Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person.
- [F2]The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F3]The Issuer cancelled the Stock Option in exchange for a new Stock Option having a lower exercise price.
- [F4]The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the "Vesting Start Date"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F5]The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, provided, that, any unvested portion of the Stock Option shall vest and become exercisable upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock, in either case, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F6]The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date.
- [F7]The Stock Option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
- [F8]On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the "Reverse Stock Split"). These securities reflect the Reverse Stock Split.
Documents
Issuer
Eargo, Inc.
CIK 0001719395
Entity typeother
Related Parties
1- filerCIK 0001827381
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:12 PM ET
- Size
- 24.1 KB